Cellosaurus logo
expasy logo

Cellosaurus Mel-XY3 (CVCL_A0GV)

[Text version]
Cell line name Mel-XY3
Synonyms MEL-XY3
Accession CVCL_A0GV
Resource Identification Initiative To cite this cell line use: Mel-XY3 (RRID:CVCL_A0GV)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2832.
Population: Caucasian.
Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
HLA typing Source: PubMed=17448240
Class I
HLA-AA*02:01,23
HLA-BB*18,18
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 43Y
Category Cancer cell line
Publications

PubMed=17448240; DOI=10.1186/1479-5876-5-19; PMCID=PMC1863425
von Euw E.M., Barrio M.M., Furman D., Bianchini M., Levy E.M., Yee C., Li Y.-Q., Wainstok de Calmanovici R., Mordoh J.
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
J. Transl. Med. 5:19.1-19.13(2007)

PubMed=21993558; DOI=10.1038/jid.2011.312
Aris M., Zubieta M.R., Colombo M., Arriaga J.M., Bianchini M., Alperovich M., Bravo A.I., Barrio M.M., Mordoh J.
MART-1- and gp100-expressing and -non-expressing melanoma cells are equally proliferative in tumors and clonogenic in vitro.
J. Invest. Dermatol. 132:365-374(2012)

Patent=US8501168
Mordoh J., Barrio M.M., von Euw E.M.
Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods.
Patent number US8501168, 06-Aug-2013

Cross-references
Encyclopedic resources Wikidata; Q108820899
Entry history
Entry creation23-Sep-2021
Last entry update29-Jun-2023
Version number4